The post U.S. Raises Global Tariff Rate From 10% To 15% appeared on BitcoinEthereumNews.com. U.S. President has announced plans to increase the global tariff rateThe post U.S. Raises Global Tariff Rate From 10% To 15% appeared on BitcoinEthereumNews.com. U.S. President has announced plans to increase the global tariff rate

U.S. Raises Global Tariff Rate From 10% To 15%

U.S. President has announced plans to increase the global tariff rate to 15% from 10%, just a day after he first announced the new global tariff. This move also follows the Supreme Court’s ruling on the Trump tariffs under IEEPA, which the court found illegal.

Trump Tariffs Increase To 15% From 10%

In a Truth Social post, Trump announced that, effectively immediately, the U.S. is raising the 10% global tariff to the “fully allowed, and legally tested” 15% level. He added that over the next few months, his administration will determine and issue the new and legally permissible tariffs.

This announcement comes just a day after Trump unveiled the 10% global tariffs following the Supreme Court’s ruling. The global tariff falls under section 122 of the Trade Expansion Act of 1962. It is also worth noting that 15% is the limit rate under this section. As such, these Trump tariffs cannot increase beyond this rate.

Meanwhile, these tariffs have a duration of just five months. However, the Trump administration can extend them with congressional approval. These global tariffs are meant ot serve as a temporary substitute after the Supreme Court struck down the Trump tariffs under the IEEPA.

The Bitcoin fell slightly following this announcement from the U.S. president, dropping from around $68,600 to around $68,200. TradingView data shows that the leading crypto is trading at around $68,300 at the time of writing.

Source: TradingView; Bitcoin Daily Chart

VanEck Chief Matthew Sigel suggested that the Supreme Court ruling could provide a major boost for BTC and the broader crypto market as money printing and debasement could accelerate. However, the Trump administration has indicated that it intends to implement the same tariff structure it had under IEEPA, using the Trade Expansion Act of 1962. As such, BTC could still face downside pressure as Trump moves to announce new tariff measures.

Source: https://coingape.com/trump-tariffs-u-s-raises-global-tariff-rate-to-15-following-supreme-court-ruling/

Market Opportunity
OFFICIAL TRUMP Logo
OFFICIAL TRUMP Price(TRUMP)
$3.476
$3.476$3.476
-1.36%
USD
OFFICIAL TRUMP (TRUMP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow

And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow

The first-ever ETFs for XRP and Dogecoin are expected to launch in the US tomorrow. Here's what you need to know. Continue Reading: And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow
Share
Coinstats2025/09/18 04:33
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Rising Altcoin Inflows Signal Potential Market Sell-Off: CryptoQuant

Rising Altcoin Inflows Signal Potential Market Sell-Off: CryptoQuant

        Highlights:  Inflows of altcoins in exchanges have surged by 22% in early 2026. An increase in deposits indicates a growing sell-side pressure. The 
Share
Coinstats2026/02/22 02:03